PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 50 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | +200.0% | 171,150 | +959.8% | 0.00% | – |
| Q2 2022 | $10,000 | -93.3% | 16,150 | -85.7% | 0.00% | -100.0% |
| Q1 2022 | $149,000 | -25.1% | 113,150 | +48.6% | 0.01% | -14.3% |
| Q4 2021 | $199,000 | -27.4% | 76,150 | -13.6% | 0.01% | -36.4% |
| Q3 2021 | $274,000 | +40.5% | 88,150 | +68.1% | 0.01% | +37.5% |
| Q2 2021 | $195,000 | – | 52,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,607,044 | $4,194,000 | 0.48% |
| NEA Management Company, LLC | 6,643,704 | $17,340,000 | 0.35% |
| Platform Technology Partners | 251,723 | $657,000 | 0.29% |
| DAFNA Capital Management LLC | 378,611 | $988,000 | 0.25% |
| Avidity Partners Management LP | 4,405,000 | $11,497,000 | 0.24% |
| Endurant Capital Management LP | 360,078 | $940,000 | 0.23% |
| Rock Springs Capital Management LP | 2,581,299 | $6,737,000 | 0.16% |
| RA Capital Management | 2,850,000 | $7,439,000 | 0.13% |
| New Legacy Group, LLC | 240,575 | $628,000 | 0.12% |
| XTX Topco Ltd | 15,574 | $41,000 | 0.02% |